Estradiol (E2); Estriol; Estrone; Estrogen Quotient; Progesterone (PG); PG/E2 Ratio; Testosterone; DHEA; Cortisol x 4
Women’s Health and Breast Profile, Saliva
Test
Report Includes
Specimens
Saliva
Clinical Utility
TheWomens Health and Breast Profileincludes two risk assessment ratios, the Estrogen Quotient and the Pg/E2 ratio. Dr. Henry Lemon developed the Estrogen Quotient (EQ) which is a simple ratio of the cancer protective E3 to the proliferative estrogens E1 and E2. According to Dr. Lemon, the EQ provides an assessment of breast cancer risk, with a lower number (<1.0) indicating increased risk, and a higher number (>1.0) signifying a lower risk. Dr. Lemons work stated that for maximum protection, an optimal EQ is >1.5. The Pg/E2 ratio, developed by Dr. John Lee, illuminates the relationship between estradiol, which is a proliferative hormone, and progesterone, which balances estradiol and slows cellular proliferation. The information gained from this profile will help to further the conversation with your patients about targeted treatment options such as BHRT, nutraceutical and herbal supplementation, as well as potential lifestyle modifications.
Source: https://www.labrix.com/SalivaTestingMenu;Accessed 27-Aug-2019.
Test Location
Doctor's Data, IL, USA
Test Version
9-May-2022
Specimen
Specimens
Saliva
Additional Information
A specimen collection kit is available. To order a kit online, please register or login. For assistance or more information, please click here to send us an email or call 416-422-3000 x 300.
Stability
Refrigerated | 10 Days |
---|---|
Frozen | 21 Days |
Test Version
9-May-2022
Performance / Interpretation
Turnaround Time
8 Days
Sample Reports
Sample Report at external website.
Test Location
Doctor's Data, IL, USA
Test Version
9-May-2022